See more : Zhonghong Pulin Medical Products Co., Ltd. (300981.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of SalMar ASA (SALRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SalMar ASA, a leading company in the Agricultural Farm Products industry within the Consumer Defensive sector.
You may be interested
- C-Rad AB (publ) (CRAD-B.ST) Income Statement Analysis – Financial Results
- Digicontent Limited (DGCONTENT.BO) Income Statement Analysis – Financial Results
- Silicom Ltd. (SILC) Income Statement Analysis – Financial Results
- Enerplus Corporation (ERF) Income Statement Analysis – Financial Results
- Roche Holding AG (RHHVF) Income Statement Analysis – Financial Results
SalMar ASA (SALRY)
About SalMar ASA
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, the United States, Canada, Norway, rest of Europe, and internationally. It is involved in the broodfish, lumpfish, and smolt production activities; and marine-phase farming, harvesting, packaging, processing, and selling farmed salmon. The company sells its products to importers/exporters, processing companies, and retail chains through in-house sales force and/or through partners. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.10B | 20.16B | 15.04B | 12.91B | 12.24B | 11.34B | 10.76B | 8.96B | 7.33B | 7.19B | 6.25B | 4.20B | 3.80B | 3.40B | 2.38B | 1.70B | 1.68B | 1.24B | 866.58M | 784.17M |
| Cost of Revenue | 11.50B | 9.60B | 6.49B | 6.32B | 6.21B | 3.90B | 5.96B | 3.25B | 3.70B | 3.49B | 2.67B | 2.15B | 2.04B | 2.01B | 1.14B | 818.17M | 788.90M | 520.55M | 429.51M | 449.02M |
| Gross Profit | 16.60B | 10.56B | 8.55B | 6.59B | 6.03B | 7.44B | 4.79B | 5.71B | 3.63B | 3.69B | 3.58B | 2.05B | 1.75B | 1.39B | 1.24B | 886.07M | 888.79M | 720.12M | 437.08M | 335.15M |
| Gross Profit Ratio | 59.08% | 52.38% | 56.84% | 51.06% | 49.28% | 65.63% | 44.54% | 63.70% | 49.54% | 51.39% | 57.26% | 48.76% | 46.21% | 40.78% | 52.16% | 51.99% | 52.98% | 58.04% | 50.44% | 42.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 73.23M | 93.67M | 63.70M | 47.20M | 53.09M | 17.71M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 87.75M | 61.38M | 44.70M | 39.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 94.78M | 33.59M | 0.00 | 249.70M | 235.45M | 1.43M | 1.01M | 119.84M |
| Selling & Marketing | 1.84B | 1.67B | 1.28B | 1.05B | 720.06M | 681.09M | 672.15M | 550.78M | 559.53M | 445.22M | 423.08M | 322.50M | 301.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.93B | 1.73B | 1.32B | 1.05B | 720.06M | 681.09M | 672.15M | 550.78M | 559.53M | 445.22M | 423.08M | 322.50M | 395.87M | 33.59M | 0.00 | 249.70M | 235.45M | 1.43M | 1.01M | 119.84M |
| Other Expenses | 6.17B | 4.70B | 3.54B | 2.70B | 2.39B | 2.34B | 1.53B | 2.06B | 1.60B | 1.44B | 1.36B | 1.12B | 3.64M | 378.51M | 643.03M | 318.23M | 241.94M | -183.50M | -147.42M | 92.55M |
| Operating Expenses | 8.09B | 6.43B | 4.86B | 3.76B | 3.11B | 3.02B | 2.21B | 2.61B | 2.16B | 1.88B | 1.78B | 1.44B | 1.15B | 412.10M | 643.03M | 567.92M | 477.39M | 209.07M | 186.60M | 212.39M |
| Cost & Expenses | 19.59B | 16.03B | 11.35B | 10.08B | 9.32B | 6.92B | 8.17B | 5.86B | 5.85B | 5.37B | 4.45B | 3.60B | 3.19B | 2.43B | 1.78B | 1.39B | 1.27B | 729.62M | 616.11M | 661.41M |
| Interest Income | 102.17M | 28.41M | 15.19M | 10.26M | 12.47M | 10.96M | 11.11M | 5.01M | 3.48M | 9.06M | 9.96M | 2.96M | 8.05M | 24.13M | 30.40M | 3.85M | 47.10M | 738.00K | 384.00K | 22.62M |
| Interest Expense | 1.22B | 364.25M | 184.65M | 149.85M | 170.19M | 116.10M | 106.96M | 106.33M | 98.78M | 124.19M | 168.05M | 150.22M | 133.78M | 64.53M | 33.20M | 72.18M | 5.07M | 29.02M | 21.40M | 10.03M |
| Depreciation & Amortization | 1.45B | 1.00B | 803.14M | 780.97M | 716.81M | 487.78M | 414.69M | 358.02M | 321.45M | 278.16M | 225.82M | 170.17M | 132.00M | 93.96M | 66.58M | 55.23M | 50.67M | 37.87M | 27.27M | 23.51M |
| EBITDA | 9.95B | 4.58B | 4.26B | 3.53B | 3.69B | 5.06B | 3.17B | 3.81B | 1.80B | 2.03B | 2.72B | 947.76M | 391.81M | 1.42B | 733.88M | 375.79M | 537.00M | 628.15M | 367.85M | 143.71M |
| EBITDA Ratio | 35.43% | 22.73% | 29.39% | 27.54% | 30.19% | 45.63% | 29.51% | 42.65% | 25.03% | 30.56% | 40.97% | 21.36% | 22.87% | 41.79% | 31.37% | 21.25% | 32.01% | 51.92% | 42.45% | 18.33% |
| Operating Income | 8.51B | 3.54B | 3.45B | 2.83B | 3.03B | 4.31B | 2.79B | 3.09B | 1.44B | 1.65B | 1.95B | 638.86M | 601.34M | 1.15B | 580.14M | 304.47M | 505.63M | 511.05M | 250.47M | 122.76M |
| Operating Income Ratio | 30.28% | 17.58% | 22.94% | 21.90% | 24.80% | 37.97% | 25.96% | 34.43% | 19.71% | 22.92% | 31.21% | 15.19% | 15.84% | 33.94% | 24.41% | 17.87% | 30.14% | 41.19% | 28.90% | 15.65% |
| Total Other Income/Expenses | -1.23B | -176.13M | -64.03M | -256.32M | 123.76M | 145.93M | 63.99M | 256.48M | -60.12M | -183.01M | 372.65M | -30.36M | -440.86M | 106.97M | 53.97M | -69.76M | -24.37M | 66.27M | 68.71M | -12.59M |
| Income Before Tax | 7.28B | 4.56B | 3.39B | 2.57B | 3.16B | 4.45B | 2.86B | 3.34B | 1.38B | 1.63B | 2.32B | 608.50M | 160.48M | 1.26B | 634.10M | 234.70M | 481.26M | 577.32M | 319.19M | 110.17M |
| Income Before Tax Ratio | 25.91% | 22.63% | 22.51% | 19.92% | 25.81% | 39.26% | 26.56% | 37.29% | 18.89% | 22.67% | 37.18% | 14.47% | 4.23% | 37.08% | 26.68% | 13.77% | 28.69% | 46.53% | 36.83% | 14.05% |
| Income Tax Expense | 4.53B | 954.00M | 718.82M | 563.36M | 613.88M | 873.34M | 558.40M | 691.09M | 254.89M | 413.36M | 418.70M | 127.06M | 13.11M | 302.67M | 163.22M | 65.87M | -129.43M | 132.23M | 66.97M | -26.69M |
| Net Income | 3.20B | 3.31B | 2.62B | 1.98B | 2.49B | 3.57B | 2.27B | 2.64B | 1.10B | 1.19B | 1.79B | 467.37M | 147.37M | 958.12M | 470.89M | 168.83M | 351.83M | 445.02M | 252.22M | 83.48M |
| Net Income Ratio | 11.40% | 16.43% | 17.39% | 15.33% | 20.33% | 31.46% | 21.14% | 29.42% | 15.06% | 16.60% | 28.66% | 11.12% | 3.88% | 28.18% | 19.82% | 9.91% | 20.97% | 35.87% | 29.11% | 10.65% |
| EPS | 24.33 | 27.65 | 22.61 | 17.52 | 22.06 | 7.90 | 5.06 | 5.88 | 2.46 | 2.66 | 3.95 | 1.05 | 0.36 | 2.33 | 1.15 | 0.41 | 0.86 | 1.11 | 0.63 | 0.21 |
| EPS Diluted | 24.33 | 27.60 | 22.57 | 17.49 | 22.03 | 7.90 | 5.05 | 5.86 | 2.46 | 2.66 | 3.95 | 1.05 | 0.36 | 2.33 | 1.15 | 0.41 | 0.86 | 1.11 | 0.63 | 0.21 |
| Weighted Avg Shares Out | 131.64M | 119.80M | 115.71M | 112.95M | 112.77M | 451.74M | 449.34M | 448.61M | 448.08M | 448.00M | 453.20M | 446.33M | 412.00M | 412.00M | 410.85M | 411.69M | 407.82M | 400.00M | 400.00M | 400.00M |
| Weighted Avg Shares Out (Dil) | 131.63M | 119.98M | 115.92M | 113.16M | 112.92M | 451.74M | 450.70M | 450.21M | 449.05M | 448.00M | 453.20M | 446.33M | 412.00M | 412.00M | 410.85M | 411.69M | 407.82M | 400.00M | 400.00M | 400.00M |
SalMar - Sale by primary insiders in connection with release of employee restricted share units completed
Reference is made to the stock exchange announcement published by SalMar ASA ("the Company") on 19 November 2024 regarding the release of shares to participants in the Company's RSU program, and the participants ordering a third party to immediately sell...
SalMar - Release of employee restricted share units
1. Participants in the Company's RSU program have on November 19th 2024, settled a total number of 155 752 RSUs. Following the release, 155 752 shares will be transferred from the Company's holding of own shares. Subsequent to the transaction the Company...
SalMar ASA (SALRF) Q3 2024 Earnings Call Transcript
SalMar ASA (OTCPK:SALRF) Q3 2024 Earnings Conference Call November 18, 2024 4:00 AM ET Company Participants Frode Arntsen - Chief Executive Officer Ulrik Steinvik - Chief Financial Officer Conference Call Participants Frode Arntsen Good morning, everyone and welcome to the...
SalMar - Satisfactory financial results despite a period marked by biological challenges
“Although the results are affected by challenges at sea, the results also show that the structure we have at SalMar is solid and rigged to handle challenging periods, which makes the financial results acceptable during the period. Going forward, we...
SalMar - Invitation to presentation of the third quarter 2024 results
SalMar presents results for the third quarter 2024 on Monday 18 November 2024 at 08:00 CET. The presentation will be held at Hotel Continental in Stortingsgaten 24/26 in Oslo.
SalMar: Biological Threats May Hamper Q3 And Q4
SalMar ASA guidance will be tough to meet this year, we believe, based on some early data, but more importantly on reports of emerging biological threats of sea lice and jellyfish. These being difficult to predict, unforeseen and relatively recent...
SalMar – Q3 2024 Trading update
Consolidated harvest volumes in Q3 2024 are:Farming Central Norway: 38.2Farming Northern Norway: 18.3SalMar Aker Ocean: 2.1Icelandic Salmon: 1.8 Total: 60.3
SalMar - Extension of Commercial Paper
Reference is made to the stock exchange notice sent Tuesday 10 September 2024.SalMar ASA (rated BBB+ by Nordic Credit Rating) has completed a NOK 500,000,000 tap issue of its commercial paper NO0013334847 to a total outstanding amount of NOK 1...
SalMar - Issuance of Commercial Paper
SalMar ASA (rated BBB+ by Nordic Credit Rating) has issued a new commercial paper of NOK 500,000,000. Issue date: 13 September 2024 Maturity date: 13 March 2025 Coupon: 5.13 % p.a. Manager: DNB Markets
SalMar ASA (SALRF) Q2 2024 Earnings Call Transcript
SalMar ASA (OTCPK:SALRF) Q2 2024 Earnings Conference Call August 20, 2024 4:00 AM ET Company Participants Frode Arntsen - Chief Executive Officer Ulrik Steinvik - Chief Financial Officer Frode Arntsen Good morning, everyone, and welcome to the presentation of SalMar...
Source: https://incomestatements.info
Category: Stock Reports